observational
    2015

    Molybdenum cofactor deficiency: metabolic basis and treatment with cyclic pyranopterin monophosphate

    Schwahn BC, Van Spronsen FJ, Belaidi AA

    Published in The Lancet

    Key Findings

    Substitution therapy with cPMP improved survival and neurological outcome in molybdenum cofactor deficiency type A.

    Conclusions

    Genetic cofactor disorder, not dietary deficiency.

    Limitations

    Rare disease case series.

    Supplements Studied

    Molybdenum
    Mineral

    Molybdenum cofactor deficiency is a genetic disorder treated with cPMP, not with dietary molybdenum.

    Study Details

    Year:2015
    Sample Size:11
    Quality Score:6/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.